  <script type="text/javascript">
    $(document).ready(function () {

    if (bowser.msie) {
       var width = 'width';
       var height = 'height';
    }
    else{
        var width = 'innerWidth';
        var height = 'innerHeight';
    }

    $( "#prev_SLIT_slide, #next_SLIT_slide" ).click(function() {
        var page = ( $(this).attr( "id" ) === "prev_SLIT_slide" ) ? 40 : 42;
        $( "span.count" ).empty().html(page + "/66" );
        $( "span#SLITslide_no" ).text(page);
        
        target = $(this).attr( "alt" );
        target = "../../programs/AIT/SLIT/" + target;

        /* make an ajax call to retrieve next slide */
        $.ajax(
          {url:target,
            cache: false,
            type: "GET",
            dataType: "html"
          }) 

        .done(function( data ) {
              $( "#SLIT_section" ).empty();
              $( "#SLIT_section" ).html( data );
        })
         .fail(function() {
             var no_data = "<table><tr><td> We are sorry, the contents you requested do not exist! </td></tr></table>";
            $( "#SLIT_section" ).html( no_data );
        });
        
    });

    $( "#SLIT_Slide34" ).click(function() {
          window.open('https://dxlink.ca/fr/programs/AIT/images/Slide34_large.jpg','_blank','' + width + '=750px,' + height + '=563px,menubar=no,location=yes,resizable=yes,scrollbars=yes,status=no');
    });

  });//end document.ready
</script>
<div class="innerContentFrame">
   <table style="width:100%;" >
      <tr valign="top">
        <td style="vertical-align:top;padding: 0 0 25px 5px; width:595px" >
      
          <div style="padding0;margin0;">
              <span class="subTitle">Indice pollinique et indice total des symptômes de la rhinoconjonctivite (ITSR) moyens par groupes de traitement de l’étude</span></br>
                <p style="padding-top:10px;"> <span class="thumb-screen three-line-spaced" id="SLIT_Slide34"></span><img style="float:right; margin: 0px 0px 10px 25px;cursor: pointer;" src="images/Slide34_small.jpg" width="200" height="150"/>Les doses 300 IR (indice de réactivité) et 500 IR ont réduit de façon significative l’indice total des symptômes de la rhinoconjonctivite moyen (3,58 +/- 3,0, p = 0,0001; et 3,74 +/- 3,1, p = 0,0006, respectivement) par rapport au placebo (4,93 +/- 3,2) dans les populations en intention de traiter et évaluables selon le protocole. L’indice du groupe recevant la dose 100 IR (4,70 +/- 3,1) n’a pas présenté de différence significative par rapport à celui du groupe placebo. </p>
                </br>
                <p class="info_reference">Référence :</br>Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol, 2007; 120(6):1338-1345.</p>                      
          </div>
        </td>
         <td style="padding:0 10px 0 30px;">
          <img style="cursor: pointer;" src="../images/prev.jpg" width="28" height="28"  alt="AIT_SLIT_slide_19.html" id="prev_SLIT_slide"/>
        </td>
        <td style="padding: 0;">
          <img style="cursor: pointer;" src="../images/next.jpg" width="28" height="28" alt="AIT_SLIT_slide_21.html" id="next_SLIT_slide"/>
        </td>
    </tr> 
    </table>
</div>